ReviewMedizinische Klinik, Intensivmedizin und Notfallmedizin2025
Understanding cancer disease status and what it means for intensivists.
Review in Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive value of baseline levels and early dynamic changes of ctDNA for 28-day mortality in ICU patients with advanced lung cancer: a prospective single-center cohort study.Frontiers in molecular biosciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A thorough understanding of oncological disease status is crucial for managing critically ill patients with cancer. The cancer trajectory predisposes patients to the type of critical illness they could develop and shapes the likelihood of reversibility and the chance for meaningful recovery, including continuation of therapy. This review outlines how disease status-whether new diagnosis, remission, stable disease, or progression-directly impacts differential diagnosis and treatment goals in the intensive care unit (ICU). Prognosis can be subdivided into (1) the comorbid cancer condition and (2) the acute critical care condition. Factors that impact prognosis may be similar including patient frailty, extent of organ failure, and tumor-related factors. While ICU survival remains an important patient-centered outcome, long-term outcomes such as return to treatment and acceptable quality of life have become increasingly important as ICU survival has improved over the past decades. Clear communication about patient values helps align care with realistic goals and avoid disproportionate ICU treatment. However, a critical element of establishing realistic goals includes a thorough understanding of the oncologic disease status. Close collaboration between intensivists and oncologists improves prognostication, treatment planning, and advance care discussions. Early recognition of high-risk patients and clear escalation or limitation pathways help ensure timely ICU transfer when needed. After ICU discharge, coordinated follow-up and rehabilitation support recovery and candidacy for further oncological treatment. An integrated, goal-directed approach enables tailored care for this complex patient group and supports shared decision-making throughout the continuum of cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.